Skip to content

APOTHEEK SOFIE DHONT: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK SOFIE DHONT

BE 0469.093.087
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€272,524
2024 · €221,972+€50,552
Equity
€224,379
2024 · €211,855+€12,524
Cash
€340,733
2024 · €134,251+€206,483
Balance sheet total
€692,188
2024 · €680,598+€11,590

Largest movements

2024 to 2025
Assets
  • Cash +€206,483

    up €206,483 (+153.8%), from €134,251 to €340,733

    mainly Net result for the year (+€272,524) and Current investments (+€200,000)

  • Current investments -€200,000

    no longer reported in 2025 (was €200,000)

  • Receivables within one year +€8,317

    up €8,317 (+5.9%), from €140,896 to €149,212

    of which Other amounts receivable: +€5,085

Equity and liabilities
  • Trade debts -€60,677

    down €60,677 (-28.6%), from €212,184 to €151,507

  • Other debts +€52,049

    up €52,049 (+22.3%), from €233,527 to €285,577

  • Profit (loss) carried forward +€12,524

    up €12,524 (+13.3%), from €93,890 to €106,414

  • Tax, wage and social debts +€7,694

    up €7,694 (+95.8%), from €8,031 to €15,725

    of which Remuneration and social security: +€7,154

Income statement
  • Gross operating margin +€58,006

    up €58,006 (+19.2%), from €302,852 to €360,858

  • Financial charges +€11,960

    up €11,960 (+691.4%), from €1,730 to €13,689

  • Staff costs -€6,180

    down €6,180 (-5.8%), from €107,258 to €101,078

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €221,972
Gross operating margin +€58,006
Staff costs +€6,180
Other operating charges -€7
Financial income -€1,835
Financial charges -€11,960
Taxes +€168
Result 2025 €272,524

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€266,483
Investment +€200,000
Financing -€260,000
Cash 2024 €134,251
Net result for the year +€272,524
Depreciation +€388
Stocks and contracts +€2,821
Receivables within one year -€8,317
Trade debts -€60,677
Tax, wage and social debts +€7,694
Other debts +€52,049
Current investments +€200,000
Contributions, distributions and other -€260,000
Cash 2025 €340,733
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €680,598 €692,188 +€11,590 +1.7%
Fixed assets 21/28 €388 - -€388
Tangible fixed assets 22/27 €388 - -€388
Plant, machinery and equipment 23 €388 - -€388
Current assets 29/58 €680,210 €692,188 +€11,978 +1.8%
Stocks and contracts in progress 3 €205,064 €202,243 -€2,821 -1.4%
Stocks 30/36 €205,064 €202,243 -€2,821 -1.4%
Amounts receivable within one year 40/41 €140,896 €149,212 +€8,317 +5.9%
Trade receivables 40 €132,152 €135,383 +€3,231 +2.4%
Other amounts receivable 41 €8,744 €13,829 +€5,085 +58.2%
Current investments 50/53 €200,000 - -€200,000
Cash at bank and in hand 54/58 €134,251 €340,733 +€206,483 +153.8%
Total equity and liabilities 10/49 €680,598 €692,188 +€11,590 +1.7%
Equity 10/15 €211,855 €224,379 +€12,524 +5.9%
Contributions 10/11 €25,000 €25,000 = 0.0%
Reserves 13 €92,965 €92,965 = 0.0%
Distributable reserves 133 €92,965 €92,965 = 0.0%
Profit (loss) carried forward 14 €93,890 €106,414 +€12,524 +13.3%
Provisions and deferred taxes 16 €15,000 €15,000 = 0.0%
Provisions for liabilities and charges 160/5 €15,000 €15,000 = 0.0%
Other liabilities and charges 164/5 €15,000 €15,000 = 0.0%
Amounts payable 17/49 €453,743 €452,809 -€934 -0.2%
Amounts payable within one year 42/48 €453,743 €452,809 -€934 -0.2%
Trade debts 44 €212,184 €151,507 -€60,677 -28.6%
Suppliers 440/4 €212,184 €151,507 -€60,677 -28.6%
Taxes, remuneration and social security 45 €8,031 €15,725 +€7,694 +95.8%
Taxes 450/3 €3,031 €3,571 +€540 +17.8%
Remuneration and social security 454/9 €5,000 €12,155 +€7,154 +143.1%
Other amounts payable 47/48 €233,527 €285,577 +€52,049 +22.3%
Remuneration, social security and pensions 62 €107,258 €101,078 -€6,180 -5.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €388 €388 = 0.0%
Other operating charges 640/8 €745 €751 +€7 +0.9%
Gross operating margin 9900 €302,852 €360,858 +€58,006 +19.2%
Operating profit (loss) 9901 €194,461 €258,640 +€64,179 +33.0%
Financial income 75/76B €34,474 €32,638 -€1,835 -5.3%
Recurring financial income 75 €34,474 €32,638 -€1,835 -5.3%
Financial charges 65/66B €1,730 €13,689 +€11,960 +691.4%
Recurring financial charges 65 €1,730 €13,689 +€11,960 +691.4%
Profit (loss) for the period before taxes 9903 €227,205 €277,589 +€50,384 +22.2%
Income taxes 67/77 €5,233 €5,065 -€168 -3.2%
Profit (loss) for the period 9904 €221,972 €272,524 +€50,552 +22.8%
Profit (loss) for the period to be appropriated 9905 €221,972 €272,524 +€50,552 +22.8%

Source: filed annual accounts (NBB), fiscal years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.